YTR 830

Known as: YTR-830 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-1988
01219841988

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Recent blood culture isolates (462 strains of Gram-negative bacilli and 288 strains of staphylococci) collected in 30 European… (More)
Is this relevant?
1988
1988
The antibacterial activity, binding to penicillin-binding proteins, and morphological changes effected by YTR 830, a sulfone beta… (More)
Is this relevant?
Review
1988
Review
1988
Following Ambler's observations, B-lactamases can be divided in four classes, probably derived from a very small number of… (More)
Is this relevant?
1987
1987
Benzhydryl 2 beta-[(1,2,3-triazol-1-yl)methyl]-2 alpha-methylpenam- 3 alpha-carboxylate 1,1-dioxide was prepared by heating… (More)
Is this relevant?
1986
1986
YTR 830, a new beta-lactamase inhibitor, is synergistic with amoxycillin in vitro against a number of beta-lactamase-producing… (More)
Is this relevant?
1984
1984
YTR 830, a new beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam against aminopenicillin-resistant… (More)
Is this relevant?